NCT05153668View on ClinicalTrials.gov

Everolimus Trial in Laryngotracheal Stenosis

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Idiopathic Subglottic Tracheal Stenosis
Interventions
DRUG

Everolimus Oral Tablet

Everolimus 1.5mg by mouth daily will be given for 42 days after dilation surgery.

Trial Locations (1)

21287

Johns Hopkins Outpatient Center, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER